Philippines puts dengue immunisation program on hold - (CTV News via NewsPoints Desk)

  • The Philippines has halted its dengue immunisation programme after Sanofi announced that severe infection can occur in some patients after vaccination with Dengvaxia, as reported CTV News Friday.

  • Philippine health secretary Francisco Duque III said further recommendation will be later this month by the World Health Organization's Strategic Advisory Group of Experts on immunisation.

  • In an analysis unveiled earlier this week, Sanofi found that patients who were not previously infected with the dengue virus prior to vaccination were more likely to experience severe dengue.

  • Duque noted that no cases of severe infection have been recognised among people vaccinated in the country.

  • The health secretary did not clarify whether legal action could be pursued against Sanofi pending a review of contracts and other documents related with Dengvaxia vaccination.

  • Sanofi spokesperson Khristine Estrada-Cabanayan stated that the company is working with Philippine health authorities, adding that the drugmaker will release a statement to address concerns.

  • FirstWord Reports: Providing insight, analysis and expert opinion on important Pharma trends and challenging issues <Click here>

To read more NewsPoints articles, click here.